ALS Limited (ASX: ALQ) - Share Price
Current share price for ALQ : $23.180 0.32 (1.36%)+
ALS Limited (ALQ), an ASX-listed company, provides comprehensive testing solutions to clients in a wide range of industries around the world. Using advanced technologies and innovative methodologies, the Company's international teams deliver testing services and personalised solutions, leveraging local expertise to drive data-driven insights for a safer, healthier world.
ALQ General Information +
| ASX Code | ALQ |
| Website | http://alsglobal.com |
| Industry/Sector | Research & Consulting Services |
| Market Cap ($M) | 11,764 |
| ALQ Share Price | $23.180 |
| Day High | $23.620 |
| Day Low | $23.030 |
| Last Close | $23.500 |
| ALQ Share Price Movement | $0.32 ( 1.36% ) |
Prices as at 16:40, 16 Jun 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
ALS Limited (ALQ) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| HFResult | 23.1¢ | 30% | 12 Jun 2026 | 3 Jul 2026 | - | - | - |
| Result | 19.4¢ | 29.90% | 26 Nov 2025 | 17 Dec 2025 | - | - | - |
| HFResult | 19.7¢ | 30% | 3 Jul 2025 | 25 Jul 2025 | - | - | - |
See all dividends from ALS Limited (ALQ) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
ALS Limited (ALQ) price-sensitive announcements
ALQ - S&P DJI Announces June 2026 Quarterly Rebalance
S&P Dow Jones Indices announced the June 2026 quarterly rebalance of the S&P/ASX Indices,
ALS Limited (ALQ)
5 Jun 2026 | 5:12 PM
5 Jun 2026 | 5:12 PM
ALQ - ALS Full Year Results Investor Presentation
ALS Limited reported robust financial results for FY26, showcasing a 10.7% increase in rev
ALS Limited (ALQ)
18 May 2026 | 8:24 AM
18 May 2026 | 8:24 AM
ALQ - ALS Full Year results
ALS Limited achieved a record financial performance in FY26, with a 10.7% increase in reve
ALS Limited (ALQ)
18 May 2026 | 8:23 AM
18 May 2026 | 8:23 AM
ALQ - Full Year Statutory Accounts
The full-year statutory accounts for ALS Limited for the year ended 31 March 2026 highligh
ALS Limited (ALQ)
18 May 2026 | 8:23 AM
18 May 2026 | 8:23 AM
ALS Limited (ALQ) Recent ASX Announcements
ALQ Financial Summary
| Year to Mar | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026F | $342.85 | $70.81 | 16.40% | 23.64 | 42.49 | 2.54% | 19.9% |
| 2025F | $294.47 | $60.82 | -0.70% | 27.52 | 36.49 | 2.18% | 19.9% |
| 2024A | $296.50 | $61.24 | -3.70% | 19.60 | 39.20 | 3.27% | 20.0% |
ALQ Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | ||
| ALS Limited (ALQ) | $11,440M | 0.2288 | 0.1970 | 0.1172 | 29.3490 | 24.5187 | 21.9474 | 1.89% | 2.34% | 2.61% |
| IPH Limited (IPH) | $1,090M | -0.0218 | 0.4743 | 0.0185 | 13.1107 | 8.8926 | 8.7315 | 8.61% | 8.88% | 9.22% |
ALQ Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.79 | 29.40 | 7.02 | 1.88 |
| Market | 0.57 | 17.30 | 1.58 | 1.03 |
| Sector | 0.65 | 19.40 | 2.20 | 1.06 |
ALQ Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Malcom Deane | Chief Strategy Officer, General Manager, Life Sciences - Food & Pharma Americas, General, Chief Executive Officer, Managing Director | 7 Mar 2023 |
| Dr John Francis Mulcahy | Non-Executive Director | 1 Feb 2012 |
| Ms Christina (Christy) Boyce | Non-Executive Director | 1 Sep 2025 |
| Ms Leslie A Desjardins | Non-Executive Director | 21 Nov 2019 |
| Dr Siddhartha Kadia | Non-Executive Director | 15 Jan 2019 |
| Ms Erica Mann | Non-Executive Director | 1 Mar 2024 |
| Mr Peter Possemiers | Non-Executive Director | 1 Nov 2022 |
| Ms Catharine Farrow | Non-Executive Director | 24 Mar 2025 |
| Mr Nigel David Garrard | Non-Executive Director, Non-Executive Chairman | 7 Jun 2023 |
ALS Limited (ALQ) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 29 May 2026 | FARROW, Catharine | Buy | Direct Shares | 4,200 | $23.911 | $100,425.360 |
| 27 May 2026 | DESJARDINS, Leslie | Buy | Direct Shares | 1,200 | $23.583 | $28,300.100 |
| 2 Dec 2025 | DEANE, Malcom | Sell | Direct Shares | 7,356 | $21.930 | $161,317.080 |
See all changes in directors' interest & trades for ALS Limited (ALQ) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
ALQ Management
| Name | Position |
|---|---|
| Stuart Hutton | Chief Financial Officer |
| Dayna Field | Company Secretary,General Counsel |
| Tim Kilmister | GM Environmental |
| Andreas Jonsson | GM Food & Pharma |
| Bruce McDonald | GM Geochemistry |
ALQ Calendar of Events
| Date | Event |
|---|---|
| 17 May 2027 | Report (Prelim) |
| 17 November 2026 | Report (Interim) |
| 03 July 2026 | Div Pay Date |
| 26 June 2026 | Report (Annual) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
